Joint (JYNT)

Nasdaq Market Closed

The Joint Corp. is a U.S. chiropractic clinic operator and franchisor built around a retail healthcare model. Through The Joint Chiropractic brand, the company develops, owns, supports and franchises clinics that provide chiropractic care in accessible retail locations across the United States.

The company’s clinics are designed to make chiropractic treatment more convenient for consumers. Patients can typically seek care without the traditional insurance-driven structure common in many healthcare settings, and the brand emphasizes walk-in access, recurring wellness visits and affordable membership or package-based options. Chiropractors in the network evaluate patients and create treatment plans intended to address pain, mobility issues and ongoing preventive care needs.

The Joint’s business model combines franchising with company-owned and managed clinics. Its franchise operations generate revenue by granting franchisees access to the company’s brand, operating system, training, marketing support and other intellectual property. The model allows the company to expand its clinic footprint through independent operators while maintaining a standardized consumer experience under a national brand.

For investors, The Joint represents exposure to the intersection of consumer healthcare, wellness services and franchised retail. Demand is tied to patient traffic, clinic openings, franchisee performance, brand awareness and broader consumer willingness to pay out of pocket for routine chiropractic care. The company operates in a fragmented chiropractic market, where its distinctive positioning comes from creating a recognizable, scaled clinic network rather than relying solely on traditional solo-practice care.

8.27 USD
8.25 USD
−0.40 (-4.61%)
Pre-market

Last updated

Market Cap
117.89M
P/E
36.4
P/FCF
44.39
P/S
2.08
Enterprise Value
98.24M
Sector
Financials
Industry
Patent Owners and Lessors
Address
16767 N PERIMETER DRIVE, SCOTTSDALE, AZ, 85260
GlobeNewswire Inc.

The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California

12 Dec 2025, 08:52 AM
GlobeNewswire Inc.

The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges

31 July 2025, 08:48 AM
Zacks Investment Research

Valneva (VALN) Gets EC's Approval on Chikungunya Vaccine - Zacks Investment Research

09 July 2024, 03:01 AM
Zacks Investment Research

Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch

03 July 2024, 00:40 AM
Zacks Investment Research

National Vision (EYE) Gains Market Share Despite Macro Woes

01 July 2024, 22:55 PM
Zacks Investment Research

Neogen (NEOG) Expands in Food Safety With Petrifilm Feeder Launch

28 June 2024, 21:54 PM
Zacks Investment Research

Quest Diagnostics (DGX) Inks Deal to Acquire Allina Health

27 June 2024, 23:43 PM
Zacks Investment Research

Charles River (CRL) Inks CDMO Deal With Gates Institutes

26 June 2024, 21:46 PM
Zacks Investment Research

Asensus Surgical (ASXC) Announces New Hospital Tie-Up on Senhance

26 June 2024, 02:47 AM
Zacks Investment Research

Alcon (ALC) Achieves FDA 510(k) Clearance for Unity VCS and Unity CS

24 June 2024, 23:37 PM
Zacks Investment Research

Inspira (IINN) Unveils Business Targets for 2024-25

22 June 2024, 01:12 AM
Zacks Investment Research

Thermo Fisher (TMO) Unveils New Research Laboratory in WI

21 June 2024, 01:39 AM
Zacks Investment Research

Haemonetics (HAE) Expands VASCADE Line With New Limited Launch

20 June 2024, 03:26 AM
GlobeNewswire Inc.

The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts

13 May 2024, 21:05 PM
GlobeNewswire Inc.

The Joint Corp. to Participate in Upcoming Investor Conferences

07 May 2024, 21:05 PM
Zacks Investment Research

The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates

03 May 2024, 08:05 AM
GlobeNewswire Inc.

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results

18 Apr 2024, 21:05 PM
Zacks Investment Research

The Joint Corp. (JYNT) Upgraded to Buy: What Does It Mean for the Stock?

13 Mar 2024, 03:00 AM
Zacks Investment Research

The Joint Corp. (JYNT) Moves 10.1% Higher: Will This Strength Last?

13 Mar 2024, 01:44 AM
Zacks Investment Research

The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics

12 Mar 2024, 02:09 AM
Market Cap
117.89M
Enterprise Value
98.24M
P/E
36.4
P/B
7.62
P/S
2.08
EV / EBITDA
40.82
EV / Sales
1.73
EPS
0.23
Dividend Yield
0%
P/FCF
44.39
P/CF
29.02
Free Cash Flow
2.66M
ROE
20.94%
ROA
5.59%
Debt / Equity
0.07
Current Ratio
5.44
Quick Ratio
5.44
Cash
2.31
Avg Volume
68.86K
Fundamentals Snapshot Price
8.27

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 14.82M 15.17M 13.38M 13.27M 13.08M
Gross profit 12.1M 12.35M 10.72M 10.5M 10.11M
Operating income 873.67K 750.31K 160.92K -1.14M -678.53K
EBITDA 1.3M 1.19M 623.96K -714.31K -288.25K
Net income 1.3M 991.1K 855.01K 93.36K 967.8K
Basic EPS 0.09 0.07 0.06 0.01 0.06
Diluted EPS 0.09 0.07 0.06 0.01 0.06

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 57.92M 60.97M 69.39M 73.18M 80.09M
Total liabilities 42.43M 45.89M 46.66M 49.92M 57.26M
Total equity 15.49M 15.08M 22.72M 23.26M 22.84M
Cash & equivalents 20.68M 23.6M 29.7M 29.81M 21.92M
Current assets 48.85M 51.39M 59.49M 62.56M 69.75M
Current liabilities 8.97M 11.45M 10.17M 10.13M 9.95M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow -1.48M 2.9M 1.77M 868.65K -3.7M
Investing cash flow -234.6K -349.4K -317.84K 7.23M -291.41K
Financing cash flow -1.16M -8.96M -1.74M 0 893.18K
Change in cash -2.88M -6.41M -286.22K 8.1M -3.1M
Kind Filing Date Link
edgar index 4 — JOINT Corp View Filing
edgar index 4 — JOINT Corp View Filing
edgar index 4 — JOINT Corp View Filing
edgar index 4 — JOINT Corp View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Rubel Matthew E View Filing
form 4 Form 4 — Karrmann Sandra R View Filing
form 4 Form 4 — DaVella Ronald V View Filing
form 4 Form 4 — Grandpre Christopher M View Filing
edgar index SCHEDULE 13G/A — JOINT Corp View Filing
edgar index 4 — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index 10-Q — JOINT Corp View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — JOINT Corp View Filing
edgar index SCHEDULE 13G/A — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index DEF 14A — JOINT Corp View Filing
edgar index DEFA14A — JOINT Corp View Filing
edgar index SCHEDULE 13G/A — JOINT Corp View Filing
edgar index SCHEDULE 13D/A — JOINT Corp View Filing
edgar index 10-K — JOINT Corp View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — JOINT Corp View Filing
edgar index 4 — JOINT Corp View Filing
form 4 Form 4 — Bowman Scott Justin View Filing
form 4 Form 4 — Razdan Sanjiv Kumar View Filing
edgar index 4 — JOINT Corp View Filing
edgar index 4 — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index 4 — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index 8-K/A — JOINT Corp View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — JOINT Corp View Filing
edgar index SCHEDULE 13G — JOINT Corp View Filing
edgar index SCHEDULE 13D/A — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index 4 — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index 4 — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index 4 — JOINT Corp View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index 3 — JOINT Corp View Filing
form 3 Form 3 — JOBSON CHARLES E View Filing
form 4 Form 4 — JOBSON CHARLES E View Filing
edgar index SCHEDULE 13G/A — JOINT Corp View Filing
edgar index 10-Q — JOINT Corp View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
edgar index 8-K — JOINT Corp View Filing
eight k text 8-K — 8-K View Filing
edgar index S-8 — JOINT Corp View Filing
edgar index 144 — JOINT Corp View Filing